These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease. Cengiz M; Ozenirler S Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1293-9. PubMed ID: 26302023 [TBL] [Abstract][Full Text] [Related]
24. Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis. Siddiqui MS; Sterling RK; Luketic VA; Puri P; Stravitz RT; Bouneva I; Boyett S; Fuchs M; Sargeant C; Warnick GR; Grami S; Sanyal AJ Gastroenterology; 2013 Dec; 145(6):1271-9.e1-3. PubMed ID: 23973920 [TBL] [Abstract][Full Text] [Related]
25. Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Meroni M; Longo M; Lombardi R; Paolini E; Macchi C; Corsini A; Sirtori CR; Fracanzani AL; Ruscica M; Dongiovanni P Hepatol Commun; 2022 Mar; 6(3):535-549. PubMed ID: 34677008 [TBL] [Abstract][Full Text] [Related]
26. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography. Tsai E; Lee TP Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062 [TBL] [Abstract][Full Text] [Related]
27. Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales. Michalak A; Cichoż-Lach H; Guz M; Kozicka J; Cybulski M; Jeleniewicz W; Stepulak A World J Gastroenterol; 2020 Dec; 26(47):7538-7549. PubMed ID: 33384553 [TBL] [Abstract][Full Text] [Related]
28. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD. Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634 [TBL] [Abstract][Full Text] [Related]
29. Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease. Jiang ZG; Tapper EB; Kim M; Connelly MA; Krawczyk SA; Yee EU; Herman MA; Mukamal KJ; Lai M J Clin Gastroenterol; 2018; 52(5):444-451. PubMed ID: 28362682 [TBL] [Abstract][Full Text] [Related]
30. Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan Oeda S; Takahashi H; Imajo K; Seko Y; Ogawa Y; Moriguchi M; Yoneda M; Anzai K; Aishima S; Kage M; Itoh Y; Nakajima A; Eguchi Y J Gastroenterol; 2020 Apr; 55(4):428-440. PubMed ID: 31654131 [TBL] [Abstract][Full Text] [Related]
31. Plasma Cytokeratin-18 Level As a Novel Biomarker for Liver Fibrosis in Children With Nonalcoholic Fatty Liver Disease. Mandelia C; Collyer E; Mansoor S; Lopez R; Lappe S; Nobili V; Alkhouri N J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):181-7. PubMed ID: 26835904 [TBL] [Abstract][Full Text] [Related]
32. A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic Fatty liver disease. Mansoor S; Collyer E; Alkhouri N Curr Gastroenterol Rep; 2015 Jun; 17(6):23. PubMed ID: 26031832 [TBL] [Abstract][Full Text] [Related]
33. Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease. Jiang ZG; Tapper EB; Connelly MA; Pimentel CF; Feldbrügge L; Kim M; Krawczyk S; Afdhal N; Robson SC; Herman MA; Otvos JD; Mukamal KJ; Lai M Liver Int; 2016 Aug; 36(8):1213-20. PubMed ID: 26815314 [TBL] [Abstract][Full Text] [Related]
34. Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease. Duseja A; Singh SP; Mehta M; Shalimar ; Venkataraman J; Mehta V; Devadas K; Kar SK; Goyal O; Nagral A; Saigal S; Nijhawan S; Praharaj D; Shukla A; Sharma B; Narayanasamy K; Kumar P; Rao PN; Arora A; Mehta R; Asati P; Ranjan P; Koshy A; Alam S; Mukewar S; Mukewar S; Mohan Prasad VG; Rastogi M; Sanyal AJ Metab Syndr Relat Disord; 2022 Apr; 20(3):166-173. PubMed ID: 35085026 [No Abstract] [Full Text] [Related]
35. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease. Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086 [TBL] [Abstract][Full Text] [Related]
36. Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan. Agarwal L; Aggarwal S; Shalimar ; Yadav R; Dattagupta S; Garg H; Agarwal S Obes Surg; 2021 Feb; 31(2):617-626. PubMed ID: 33052552 [TBL] [Abstract][Full Text] [Related]
37. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease. Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578 [TBL] [Abstract][Full Text] [Related]